The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

The Serum Institute of India collaborates with the Drugs for Neglected Diseases initiative to develop a monoclonal antibody ...

The collaboration will focus on advancing the potential drug candidate—formerly known as VIS513—through Phase III clinical ...

WASHINGTON – The Food and Drug Administration has approved a new monoclonal antibody to protect infants from RSV. The ...

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.

THURSDAY, June 12, 2025 (HealthDay News) — A newly approved shot could soon help protect babies from respiratory syncytial ...

Study reveals the advantages and pitfalls of adding a TKI to a monoclonal antibody after chemoradiation for non-small cell ...

Serum Institute of India and DNDi collaborate to accelerate development of an affordable dengue monoclonal antibody treatment ...

The Serum Institute of India (SII), the world’s largest vaccine manufacturer and Drugs for Neglected Diseases initiative ...

Serum Institute of India and DNDi partner to develop affordable dengue treatment, conducting Phase III trials in multiple countries.